Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Multicolor flow cytometric analysis of CD138 (Syndecan-1) expression on Mouse bone marrow B lymphocytes. C57BL/6 Mouse bone marrow cells were stained with APC Rat Anti-Mouse CD45R/B220 antibody (Cat. No. 553092/561880) and with either BD Horizon™ BV786 Rat IgG2a, κ Isotype Control (Cat. No. 563335; Left Plot) or BD Horizon™ BV786 Rat Anti-Mouse CD138 (Syndecan-1) antibody (Cat. No. 569692; Right Plot) at 0.06 µg/test. BD Via-Probe™ Cell Viability 7-AAD Solution (Cat. No. 555815/555816) was added to cells right before analysis. The bivariate pseudocolor density plot showing the expression of CD138 (Syndecan-1) [or Ig Isotype control staining] versus CD45R/B220 was derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) bone marrow cells. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The 281-2 monoclonal antibody specifically binds to the core protein of CD138 (Syndecan-1), a cell-surface, integral membrane heparan sulfate- and chondroitin sulfate-containing proteoglycan that binds to interstitial extracellular matrix molecules. Syndecan-1 is predominantly expressed on epithelial cells, where its expression correlates with normal epithelial organization. It is also expressed on B lymphocytes at specific stages during their differentiation: precursor B cells in the bone marrow, and antibody-secreting cells including plasma cells (but not mature peripheral B cells). It is thus implicated in mediating B cell-matrix interactions. CD138 expression is also regulated during embryonic development, and the molecule shows a tissue- specific structural polymorphism resulting from different post-translational modifications. The 281-2 antibody may be used to detect the differently glycosylated forms, because it reacts with the core protein. Furthermore, the mAb detects the Syndecan-1 ectodomain which is cleaved from cell surfaces by a metalloproteinase.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.